Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
Date:7/14/2008

usion of the call through July 21, 2008 by calling (877) 344-7529, passcode 382933#.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio- manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company may experience delays in clinical trial patient enrollment, the results of future clinical trials may not correlate with the results from prior clinical and preclinical studies, the risk that Avid's revenue growth may slow or decline, the risk that Avid may experience technical difficulties in processing customer orders which could delay delivery of products to customers and receipt of payment, the risk that a one or more existing Avid customers terminates its contract prior to completion, the risk that the company does not receive all of its funding under the DTRA contract, the risk that future pro
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
2. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
3. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
4. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
5. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
6. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
7. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
10. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
11. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... Northwest Biotherapeutics (NASDAQ: NWBO ) ... personalized immune therapies for solid tumor cancers, announced today ... American Society Of Clinical Oncology (ASCO) meeting in ... in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... pre-eminent conference focused on clinical treatment of cancer, with ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 During ... is critical to adhere to principles of good ... , Esteemed speaker Dr. Jeremy Lim, Fellow, Clinical ... , ,     Understand the International Conference ... (GCP) and additional regulations for the conduction of ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 Bed ... battle against the pests is still ongoing, a report from ... thousands more for the bed bug treatment. Meanwhile, to be ... an apartment from the costly bed bug exterminator ... 2013, stated that AHA has so far spent ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
... , , IMAP APPLICATION ... By Liz Gaudet, Ph.D., Joyce Itatani, Francisco, Ramirez and Annegret Boge, ... , INTRODUCTION ... drug discovery. Many suppliers offer a profiling, ...
... , , IONWORKS HT APPLICATION NOTE #4 , ... Chen, Ph.D., Jinfang Liao, Ph.D., , Jeff Quast, Andrew Wittel, ... Corporation, 3280 Whipple Road, Union City, CA 94587., INTRODUCTION ... largely untapped portion of the potential drug, ...
... , ... , ... Application Guide ........................................................................................................................2 , ... ................................................................................................................................2 , ...
Cached Biology Technology:Setting up a kinase profiler with IMAP 2Setting up a kinase profiler with IMAP 3Setting up a kinase profiler with IMAP 4Setting up a kinase profiler with IMAP 5Setting up a kinase profiler with IMAP 6Setting up a kinase profiler with IMAP 7Setting up a kinase profiler with IMAP 8Setting up a kinase profiler with IMAP 9Setting up a kinase profiler with IMAP 10Setting up a kinase profiler with IMAP 11Setting up a kinase profiler with IMAP 12Setting up a kinase profiler with IMAP 13Setting up a kinase profiler with IMAP 14Setting up a kinase profiler with IMAP 15Setting up a kinase profiler with IMAP 16Setting up a kinase profiler with IMAP 17Setting up a kinase profiler with IMAP 18Setting up a kinase profiler with IMAP 19Setting up a kinase profiler with IMAP 20Setting up a kinase profiler with IMAP 21Setting up a kinase profiler with IMAP 22Setting up a kinase profiler with IMAP 23Setting up a kinase profiler with IMAP 24Setting up a kinase profiler with IMAP 25Setting up a kinase profiler with IMAP 26Setting up a kinase profiler with IMAP 27Setting up a kinase profiler with IMAP 28Setting up a kinase profiler with IMAP 29Setting up a kinase profiler with IMAP 30Setting up a kinase profiler with IMAP 31Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 2Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 3Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 4Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 5Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 6
(Date:5/21/2013)... Using a "patient monitoring" device attached to a whale ... time how fishing lines changed a whale,s diving and ... whales, ability to eat and migrate, depletes their energy ... can result in a slow death. , The scientists ... a Dtag to a two-year-old female North Atlantic right ...
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... available in pharmacies and health stores, phosphatidylserine is ... and soy. Proven to improve cognition and slow ... people experiencing memory impairment. Now a team headed ... of Tel Aviv University,s Department of Human ... supplement improves the functioning of genes involved in ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2
... 10 October 2008.- During the 1950s, Austrian and Swiss ... Nepal taking photographs of the glaciers, mountains and valleys. ... spent eight months in the region at locations above ... , Now, fifty years later, the black and white ...
... From Local to Global, will be the focus of ... this single event is just one small step in ... around the world and requires immediate attention in order ... and deficiencies. The Society for Nutrition Education (SNE) encourages ...
... Pregnancy and motherhood may make us all go a little ... to mental health researchers at The Australian National University. ... Research (CMHR) at ANU suggests that despite fears mothers ... no evidence to suggest that is true. The findings have ...
Cached Biology News:'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3World Food Day brings attention to food security around the globe 2Pregnancy not turning minds to mush: Study 2
... in this kit are prepared with pure ... Biochains Mitochondria Isolation Kit is designed to ... fast and easy way. One kit is ... isolations (enriching mitochondria from 10 20 ...
... plasmid DNA preparations are prepared from ... from 1mg to multi-gram scales. ... (100mg-multi-gram) preparations are made according to ... formulated according to customer needs, and ...
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... GST•Tag™ Antibody Plate is a 96-well ... Antibody. This antibody (mouse IgG 1 ... japonicum glutathione-S-transferase (GST), and binds ... GST•Tag fusion protein in which the ...
Biology Products: